The burden of adult obesity in Canada
- PMID: 17623559
The burden of adult obesity in Canada
Abstract
Obesity is a major public health problem associated with a wide range of health problems. This study estimates the prevalence of obesity, calculates the proportion (or population-attributable fraction [PAF]) of major chronic diseases which is attributable to obesity, estimates the deaths attributable to it and projects its future prevalence trends. In Canada, the overall age-standardized prevalence proportion of obesity has increased from 10 percent in 1970 to 23% in 2004 (8 percent to 23 percent in men and 13 percent to 22 percent in women). The increasing prevalence of obesity was observed for all five age groups examined: 20-34, 35-44, 45-54, 55-64 and 65+. On average, the PAF of prevalence of selected major chronic diseases which is attributable to obesity from 1970 to 2004 has increased by 138 percent for men and by 60 percent for women. Overall, in 2004, 45 percent of hypertension, 39 percent of type II diabetes, 35 percent of gallbladder disease, 23 percent of coronary artery diseases (CAD), 19 percent of osteoarthritis, 11 percent of stroke, 22 percent of endometrial cancer, 12 percent of postmenopausal breast cancer, and 10 percent of colon cancer could be attributed to obesity. In 2004, 8,414 (95 percent CI: 6,881-9,927) deaths were attributable to obesity. If current obesity prevalence trends remain unchanged, the prevalence proportion of obesity in Canada is projected to reach 27 percent in men and 24 percent in women by the year 2010. These increases will have a profound impact on the treatment needs and prevalence of a wide variety of chronic diseases, and also on the health care system in terms of capacity issues and resource allocation.
Similar articles
-
Smoking-attributable mortality and expected years of life lost in Canada 2002: conclusions for prevention and policy.Chronic Dis Can. 2007;27(4):154-62. Chronic Dis Can. 2007. PMID: 17623561
-
Burden of disease attributable to obesity and overweight in Korea.Int J Obes (Lond). 2006 Nov;30(11):1661-9. doi: 10.1038/sj.ijo.0803321. Epub 2006 Mar 14. Int J Obes (Lond). 2006. PMID: 16534516
-
Prevalence of type 2 diabetes and other cardiovascular risk factors in a semirural area in Yemen.East Mediterr Health J. 2008 Jan-Feb;14(1):42-56. East Mediterr Health J. 2008. PMID: 18557451
-
Overview of obesity in Mainland China.Obes Rev. 2008 Mar;9 Suppl 1:14-21. doi: 10.1111/j.1467-789X.2007.00433.x. Obes Rev. 2008. PMID: 18307694 Review.
-
A review of cardiovascular risk factors in US military personnel.J Cardiovasc Nurs. 2008 Jul-Aug;23(4):338-44. doi: 10.1097/01.JCN.0000317437.75081.e7. J Cardiovasc Nurs. 2008. PMID: 18596497 Review.
Cited by
-
Impact of known risk factors on endometrial cancer burden in Chinese women.Eur J Cancer Prev. 2016 Jul;25(4):329-34. doi: 10.1097/CEJ.0000000000000178. Eur J Cancer Prev. 2016. PMID: 26075656 Free PMC article.
-
Canada's global position in life expectancy: a longitudinal comparison with the healthiest countries in the world.Can J Public Health. 2009 Jan-Feb;100(1):9-13. doi: 10.1007/BF03405484. Can J Public Health. 2009. PMID: 19263968 Free PMC article.
-
Diabetes burden in Brazil: fraction attributable to overweight, obesity, and excess weight.Rev Saude Publica. 2015;49:29. doi: 10.1590/s0034-8910.2015049005571. Epub 2015 May 19. Rev Saude Publica. 2015. PMID: 26018787 Free PMC article.
-
Rapid Reduction in Use of Antidiabetic Medication after Laparoscopic Sleeve Gastrectomy: The Newfoundland and Labrador Bariatric Surgery Cohort (BaSCo) Study.Can J Hosp Pharm. 2015 Mar-Apr;68(2):113-20. doi: 10.4212/cjhp.v68i2.1436. Can J Hosp Pharm. 2015. PMID: 25964682 Free PMC article.
-
Targeting Inflammation by Flavonoids: Novel Therapeutic Strategy for Metabolic Disorders.Int J Mol Sci. 2019 Oct 8;20(19):4957. doi: 10.3390/ijms20194957. Int J Mol Sci. 2019. PMID: 31597283 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous